CD37 and pancreatic ductal adenocarcinoma: For pancreatic ductal adenocarcinoma, the CD37-dependent adenosine pathway inhibits immune cells, leading to immune suppression and implicating that products of the nucleotide metabolism pathway function as immune regulators and promote cancer immuno-surveillance.